Jay Olson
Stock Analyst at Oppenheimer
(4.84)
# 406
Out of 4,405 analysts
1159
Total ratings
47.8%
Success rate
21.5%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Maintained: Hold | $90 → $107 | $108.53 | -1.41% | 82 | Jun 8, 2026 | |
| PRAX Praxis Precision Medicines | Rated: Buy | $750 → $650 | $266.58 | +143.83% | 6 | Jun 2, 2026 | |
| RVMD Revolution Medicines | Rated: Buy | $165 → $195 | $153.87 | +26.73% | 24 | Jun 1, 2026 | |
| ANL Adlai Nortye | Initiated Coverage: Buy | $32 | $10.33 | +209.78% | 1 | May 28, 2026 | |
| CHRS Coherus Oncology | Maintained: Buy | $10 | $1.40 | +614.29% | 4 | May 12, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $35 → $40 | $21.66 | +84.67% | 17 | May 11, 2026 | |
| NKTR Nektar Therapeutics | Maintained: Buy | $115 → $140 | $59.38 | +135.77% | 25 | May 8, 2026 | |
| NBIX Neurocrine Biosciences | Rated: Buy | $192 → $230 | $159.76 | +43.97% | 89 | May 6, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $600 | $444.93 | +34.85% | 7 | May 5, 2026 | |
| SGMT Sagimet Biosciences | Rated: Buy | $25 → $33 | $6.48 | +409.26% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $53.13 | - | 35 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $90.54 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.81 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $12.08 | +65.56% | 3 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $40 | $24.75 | +61.62% | 5 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $72 | $34.46 | +108.94% | 2 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $49.91 | - | 5 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $3.92 | +308.16% | 4 | Apr 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $2.64 | +278.79% | 5 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $250 → $275 | $200.05 | +37.47% | 98 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $36 | $4.05 | +788.89% | 31 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $12.64 | +58.23% | 8 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.7872 | +1,170.33% | 14 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $4.19 | +615.99% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $18.04 | +232.59% | 1 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $650 | $480.77 | +35.20% | 50 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $380 → $400 | $355.20 | +12.61% | 83 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.69 | +255.03% | 4 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $2.30 | +204.35% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $39.72 | +0.70% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $27 | $12.11 | +122.96% | 26 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $73.28 | +22.82% | 14 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $28.75 | +247.83% | 38 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.68 | +376.19% | 5 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $3.50 | +414.29% | 20 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.25 | - | 67 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $0.4576 | +14,104.55% | 18 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $28.80 | n/a | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $125.59 | n/a | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $11.92 | n/a | 35 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 | $21.09 | n/a | 36 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $49.80 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.50 | n/a | 19 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.21 | n/a | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $10 | $20.78 | n/a | 6 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $1.10 | n/a | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.67 | n/a | 10 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.61 | n/a | 16 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $6.65 | n/a | 9 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.05 | n/a | 10 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.26 | n/a | 6 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 8 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $9 | $2.20 | n/a | 45 | Aug 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $7 | $14.22 | n/a | 27 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.58 | n/a | 20 | Jul 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.85 | n/a | 19 | Mar 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5762 | n/a | 6 | Mar 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.90 | n/a | 9 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.97 | n/a | 8 | Jan 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.35 | n/a | 5 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2 → $0.25 | $3.66 | n/a | 5 | Mar 30, 2016 |
Incyte
Jun 8, 2026
Maintained: Hold
Price Target: $90 → $107
Current: $108.53
Upside: -1.41%
Praxis Precision Medicines
Jun 2, 2026
Rated: Buy
Price Target: $750 → $650
Current: $266.58
Upside: +143.83%
Revolution Medicines
Jun 1, 2026
Rated: Buy
Price Target: $165 → $195
Current: $153.87
Upside: +26.73%
Adlai Nortye
May 28, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $10.33
Upside: +209.78%
Coherus Oncology
May 12, 2026
Maintained: Buy
Price Target: $10
Current: $1.40
Upside: +614.29%
Denali Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $21.66
Upside: +84.67%
Nektar Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $115 → $140
Current: $59.38
Upside: +135.77%
Neurocrine Biosciences
May 6, 2026
Rated: Buy
Price Target: $192 → $230
Current: $159.76
Upside: +43.97%
Vertex Pharmaceuticals
May 5, 2026
Maintained: Buy
Price Target: $600
Current: $444.93
Upside: +34.85%
Sagimet Biosciences
May 1, 2026
Rated: Buy
Price Target: $25 → $33
Current: $6.48
Upside: +409.26%
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $53.13
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $90.54
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $5.81
Upside: -
Apr 24, 2026
Maintained: Buy
Price Target: $20
Current: $12.08
Upside: +65.56%
Apr 23, 2026
Maintained: Buy
Price Target: $25 → $40
Current: $24.75
Upside: +61.62%
Apr 22, 2026
Maintained: Buy
Price Target: $61 → $72
Current: $34.46
Upside: +108.94%
Apr 20, 2026
Rated: Hold
Price Target: n/a
Current: $49.91
Upside: -
Apr 5, 2026
Rated: Buy
Price Target: $16
Current: $3.92
Upside: +308.16%
Apr 2, 2026
Rated: Buy
Price Target: $10
Current: $2.64
Upside: +278.79%
Apr 1, 2026
Rated: Buy
Price Target: $250 → $275
Current: $200.05
Upside: +37.47%
Mar 18, 2026
Maintained: Buy
Price Target: $44 → $36
Current: $4.05
Upside: +788.89%
Mar 11, 2026
Maintained: Buy
Price Target: $20
Current: $12.64
Upside: +58.23%
Mar 11, 2026
Maintained: Buy
Price Target: $10
Current: $0.7872
Upside: +1,170.33%
Mar 9, 2026
Reiterated: Buy
Price Target: $30
Current: $4.19
Upside: +615.99%
Feb 25, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $18.04
Upside: +232.59%
Feb 9, 2026
Maintained: Buy
Price Target: $650
Current: $480.77
Upside: +35.20%
Jan 29, 2026
Maintained: Buy
Price Target: $380 → $400
Current: $355.20
Upside: +12.61%
Nov 13, 2025
Maintained: Buy
Price Target: $6
Current: $1.69
Upside: +255.03%
Nov 13, 2025
Maintained: Buy
Price Target: $7
Current: $2.30
Upside: +204.35%
Nov 13, 2025
Maintained: Buy
Price Target: $40
Current: $39.72
Upside: +0.70%
Nov 7, 2025
Maintained: Buy
Price Target: $40 → $27
Current: $12.11
Upside: +122.96%
Oct 27, 2025
Maintained: Buy
Price Target: $90
Current: $73.28
Upside: +22.82%
Oct 7, 2025
Maintained: Buy
Price Target: $100
Current: $28.75
Upside: +247.83%
Oct 7, 2025
Maintained: Buy
Price Target: $8
Current: $1.68
Upside: +376.19%
Oct 2, 2025
Maintained: Buy
Price Target: $18
Current: $3.50
Upside: +414.29%
Jun 16, 2025
Maintained: Hold
Price Target: n/a
Current: $8.25
Upside: -
Jun 16, 2025
Maintained: Buy
Price Target: $65
Current: $0.4576
Upside: +14,104.55%
Mar 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $28.80
Upside: n/a
Feb 12, 2025
Reiterated: Buy
Price Target: $115
Current: $125.59
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: $14
Current: $11.92
Upside: n/a
Nov 8, 2024
Maintained: Hold
Price Target: $17
Current: $21.09
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $95
Current: $49.80
Upside: n/a
Nov 5, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.50
Upside: n/a
Nov 4, 2024
Maintained: Buy
Price Target: $9
Current: $1.21
Upside: n/a
Oct 17, 2024
Maintained: Buy
Price Target: $9 → $10
Current: $20.78
Upside: n/a
Aug 12, 2024
Maintained: Buy
Price Target: $33
Current: $1.10
Upside: n/a
Feb 26, 2024
Rated: Hold
Price Target: n/a
Current: $1.67
Upside: n/a
Feb 14, 2023
Downgraded: Hold
Price Target: n/a
Current: $11.61
Upside: n/a
Nov 14, 2022
Upgraded: Buy
Price Target: $7
Current: $6.65
Upside: n/a
Aug 14, 2020
Rated: Hold
Price Target: n/a
Current: $9.05
Upside: n/a
Jun 12, 2020
Rated: Hold
Price Target: n/a
Current: $1.26
Upside: n/a
May 8, 2020
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 22, 2019
Maintained: Buy
Price Target: $10 → $9
Current: $2.20
Upside: n/a
Aug 14, 2019
Maintained: Buy
Price Target: $15 → $7
Current: $14.22
Upside: n/a
Jul 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.58
Upside: n/a
Mar 24, 2019
Maintained: Buy
Price Target: n/a
Current: $2.85
Upside: n/a
Mar 15, 2019
Rated: Hold
Price Target: n/a
Current: $0.5762
Upside: n/a
Dec 8, 2017
Rated: Hold
Price Target: n/a
Current: $3.90
Upside: n/a
Jan 20, 2017
Rated: Hold
Price Target: n/a
Current: $6.97
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: n/a
Current: $11.35
Upside: n/a
Mar 30, 2016
Maintained: Sell
Price Target: $2 → $0.25
Current: $3.66
Upside: n/a